CoChat

Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer’s Disease

Li, Wei-Wei, Shen, Ying-Ying, Tian, Ding-Yuan, Bu, Xian-Le, Zeng, Fan, Liu, Yu-Hui, Chen, Yang, Yao, Xiu-Qing, Li, Hui-Yun, Chen, Dong-Wan, Zhou, Fa-Ying, Yang, Heng, Li, Qi-Ming, Bao, Wei-Qi, Guan, Yi-Hui, Zhou, Hua-Dong, Jin, Rong-Bing, Wang, Yan-Jiang · 2019 · Journal of Alzheimer's Disease
Cited by 39

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Brain amyloid-β (Aβ) deposition is a hallmark to define Alzheimer's disease (AD). We investigated the positive rate of brain amyloid deposition assessed with 11C-Pittsburgh compound (PiB)-PET and blood Aβ levels in a cohort of probable AD patients who were diagnosed according to the 1984 NINCDS-ADRDA criteria. Eighty-four subjects with a clinical diagnosis of probable AD dementia, amnestic mild cognitive impairment (MCI), and cognitively normal (CN) status were subjected to PiB-PET and 18F-fluorodeoxyglucose (FDG)-PET scans. Plasma biomarkers of Aβ42, Aβ40, and T-tau were measured using single molecule array technology. The positive rate of PiB-PET, the associations between PiB-PET status and FDG-PET, plasma biomarkers, and clinical manifestations were analyzed. PiB-PET was positive in 77.36% of probable AD patients, 31.80% of MCI patients, and 0 of NC. Plasma Aβ42/Aβ40 ratio was associated with PiB-PET, the ROC curve analysis revealing an AUC of 0.77 (95% CI: 0.66-0.87), with a sensitivity of 82% and specificity of 64%. Some clinical manifestations were associated with PiB-PET imaging. Our findings indicate that only three-fourths of patients diagnosed with probable AD fit the pathological criteria, suggesting that we should be cautious regarding the accuracy of AD diagnosis when no biomarker evidence is available in our clinical practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-190056

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 39

Metadata

Authors
Li, W.-W., Shen, Y.-Y., Tian, D.-Y., Bu, X.-L., Zeng, F., Liu, Y.-H., Chen, Y., Yao, X.-Q., Li, H.-Y., Chen, D.-W., Zhou, F.-Y., Yang, H., Li, Q.-M., Bao, W.-Q., Guan, Y.-H., Zhou, H.-D., Jin, R.-B., & Wang, Y.-J.
Venue
Journal of Alzheimer's Disease
Published
2019-05-07
Volume
69
Issue
1
Pages
169-178
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2926985261
Cited by
39
References
13
FWCI
3.87
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer’s Disease. https://app.cochat.ai/papers/10.3233/jad-190056
The paper
Li, W.-W., Shen, Y.-Y., Tian, D.-Y., Bu, X.-L., Zeng, F., Liu, Y.-H., Chen, Y., Yao, X.-Q., Li, H.-Y., Chen, D.-W., Zhou, F.-Y., Yang, H., Li, Q.-M., Bao, W.-Q., Guan, Y.-H., Zhou, H.-D., Jin, R.-B., & Wang, Y.-J. (2019). Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer’s Disease. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-190056

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.